Literature DB >> 367444

Cocarcinogenesis.

A Sivak.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 367444     DOI： 10.1016/0304-419x(79)90003-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  8 in total

Review 1.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

2.  Animal experiments regarding a possible carcinogenic effect of phenacetin on the resting and proliferating urothelium stimulated by cyclophosphamide.

Authors:  E Kunze; H H Wöltjen; B Hartmann; W Engelhardt
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

3.  Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells.

Authors:  V Solanki; T J Slaga; M Callaham; E Huberman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

4.  Cocarcinogenesis and tumor promoters of the diterpene ester type as possible carcinogenic risk factors.

Authors:  E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

5.  Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice.

Authors:  V Solanki; T J Slaga
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

6.  Some basic problems in assessing carcinogenic risks.

Authors:  I Berenblum
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

7.  Induction of granulocyte-macrophage colony-stimulating activity in mouse skin by inflammatory agents and tumor promoters.

Authors:  M J Koury; A Balmain; I B Pragnell
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

8.  Regulation of plasminogen activator in 3T3 cells: effect of phorbol myristate acetate on subcellular distribution and molecular weight.

Authors:  S Jaken; P H Black
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.